Molecular Partners Ag
Clinical trials sponsored by Molecular Partners Ag, explained in plain language.
-
Radioactive 'Magic Bullet' tested against tough cancers
Disease control Recruiting nowThis study is testing a new radioactive drug called [212Pb]Pb-DOTAM-MAM279 in adults with advanced small cell lung cancer and other hard-to-treat solid tumors. The main goals are to find a safe and effective dose and to see if the treatment can shrink tumors. The drug is designed…
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Experimental drug targets tough blood cancers in first human trial
Disease control Recruiting nowThis study is testing a new drug called MP0533 for the first time in people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). Researchers want to find the safest dose and see if it helps control these blood cancers. The trial will include up to 249 adults whose…
Phase: PHASE1, PHASE2 • Sponsor: Molecular Partners AG • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC